Title : Cytochrome p450-soluble epoxide hydrolase derived linoleic acid oxylipins and cognitive performance in type 2 diabetes - Anita_2023_J.Lipid.Res__100395 |
Author(s) : Anita NZ , Kwan F , Ryoo SW , Major-Orfao C , Lin WZ , Noor S , Lanctot KL , Herrmann N , Oh PI , Shah BR , Gilbert J , Assal A , Halperin IJ , Taha AY , Swardfager W |
Ref : J Lipid Res , :100395 , 2023 |
Abstract : |
PubMedSearch : Anita_2023_J.Lipid.Res__100395 |
PubMedID: 37245563 |
Title : Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial - Lanctot_2023_Am.J.Geriatr.Psychiatry__ |
Author(s) : Lanctot KL , Rivet L , Tumati S , Perin J , Sankhe K , Vieira D , Mintzer J , Rosenberg PB , Shade D , Lerner AJ , Padala PR , Brawman-Mintzer O , van Dyck CH , Porsteinsson AP , Craft S , Levey AI , Padala KP , Herrmann N |
Ref : American Journal of Geriatry & Psychiatry , : , 2023 |
Abstract : |
PubMedSearch : Lanctot_2023_Am.J.Geriatr.Psychiatry__ |
PubMedID: 37385898 |
Title : CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia - Herrmann_2022_Alzheimers.Dement.(N.Y)_8_e12099 |
Author(s) : Herrmann N , Ismail Z , Collins R , Desmarais P , Goodarzi Z , Henri-Bhargava A , Iaboni A , Kirkham J , Massoud F , Moser A , Silvius J , Watt J , Seitz D |
Ref : Alzheimers Dement (N Y) , 8 :e12099 , 2022 |
Abstract : |
PubMedSearch : Herrmann_2022_Alzheimers.Dement.(N.Y)_8_e12099 |
PubMedID: 35128025 |
Title : Pharmacological Management of Apathy in Dementia - Azhar_2022_CNS.Drugs__ |
Author(s) : Azhar L , Kusumo RW , Marotta G , Lanctot KL , Herrmann N |
Ref : CNS Drugs , : , 2022 |
Abstract : |
PubMedSearch : Azhar_2022_CNS.Drugs__ |
PubMedID: 35006557 |
Title : Serum soluble epoxide hydrolase related oxylipins and major depression in patients with type 2 diabetes - Anita_2021_Psychoneuroendocrinology_126_105149 |
Author(s) : Anita NZ , Forkan N , Kamal R , Nguyen MM , Yu D , Major-Orfao C , Wong SK , Lanctot KL , Herrmann N , Oh PI , Shah BR , Gilbert J , Assal A , Halperin IJ , Pedersen TL , Taha AY , Swardfager W |
Ref : Psychoneuroendocrinology , 126 :105149 , 2021 |
Abstract : |
PubMedSearch : Anita_2021_Psychoneuroendocrinology_126_105149 |
PubMedID: 33503568 |
Title : Soluble Epoxide Hydrolase-Derived Linoleic Acid Oxylipins in Serum Are Associated with Periventricular White Matter Hyperintensities and Vascular Cognitive Impairment - Yu_2019_Transl.Stroke.Res_10_522 |
Author(s) : Yu D , Hennebelle M , Sahlas DJ , Ramirez J , Gao F , Masellis M , Cogo-Moreira H , Swartz RH , Herrmann N , Chan PC , Pettersen JA , Stuss DT , Black SE , Taha AY , Swardfager W |
Ref : Transl Stroke Res , 10 :522 , 2019 |
Abstract : |
PubMedSearch : Yu_2019_Transl.Stroke.Res_10_522 |
PubMedID: 30443886 |
Title : Current Agents in Development for Treating Behavioral and Psychological Symptoms Associated with Dementia - Ahmed_2019_Drugs.Aging_36_589 |
Author(s) : Ahmed M , Malik M , Teselink J , Lanctot KL , Herrmann N |
Ref : Drugs & Aging , 36 :589 , 2019 |
Abstract : |
PubMedSearch : Ahmed_2019_Drugs.Aging_36_589 |
PubMedID: 30957198 |
Title : Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary - Reeve_2019_Med.J.Aust_210_174 |
Author(s) : Reeve E , Farrell B , Thompson W , Herrmann N , Sketris I , Magin PJ , Chenoweth L , Gorman M , Quirke L , Bethune G , Hilmer SN |
Ref : Med J Aust , 210 :174 , 2019 |
Abstract : |
PubMedSearch : Reeve_2019_Med.J.Aust_210_174 |
PubMedID: 30771226 |
Title : Sex Differences in the Prevalent Use of Oral Formulations of Cholinesterase Inhibitors in Older Adults with Dementia - Zhu_2019_Drugs.Aging_36_875 |
Author(s) : Zhu L , Rochon PA , Gruneir A , Wu W , Giannakeas V , Austin PC , Stall NM , McCarthy L , Alberga A , Herrmann N , Gill SS , Bronskill SE |
Ref : Drugs & Aging , 36 :875 , 2019 |
Abstract : |
PubMedSearch : Zhu_2019_Drugs.Aging_36_875 |
PubMedID: 31309528 |
Title : Initial Cholinesterase Inhibitor Therapy Dose and Serious Events in Older Women and Men - Rochon_2018_J.Am.Geriatr.Soc_66_1692 |
Author(s) : Rochon PA , Gruneir A , Gill SS , Wu W , Zhu L , Herrmann N , Bell CM , Austin PC , Stall NM , McCarthy L , Giannakeas V , Alberga A , Seitz DP , Normand SL , Gurwitz JH , Bronskill SE |
Ref : J Am Geriatr Soc , 66 :1692 , 2018 |
Abstract : |
PubMedSearch : Rochon_2018_J.Am.Geriatr.Soc_66_1692 |
PubMedID: 30019755 |
Title : Predictors of Cholinesterase Discontinuation during the First Year after Nursing Home Admission - Maclagan_2018_J.Am.Med.Dir.Assoc_19_959 |
Author(s) : Maclagan LC , Bronskill SE , Guan J , Campitelli MA , Herrmann N , Lapane KL , Hogan DB , Amuah JE , Seitz DP , Gill SS , Maxwell CJ |
Ref : J Am Med Dir Assoc , 19 :959 , 2018 |
Abstract : |
PubMedSearch : Maclagan_2018_J.Am.Med.Dir.Assoc_19_959 |
PubMedID: 30262440 |
Title : Pharmacological interventions for apathy in Alzheimer's disease - Ruthirakuhan_2018_Cochrane.Database.Syst.Rev_5_CD012197 |
Author(s) : Ruthirakuhan MT , Herrmann N , Abraham EH , Chan S , Lanctot KL |
Ref : Cochrane Database Syst Rev , 5 :CD012197 , 2018 |
Abstract : |
PubMedSearch : Ruthirakuhan_2018_Cochrane.Database.Syst.Rev_5_CD012197 |
PubMedID: 29727467 |
Title : Comparison of prescribing practices for older adults treated by female versus male physicians: A retrospective cohort study - Rochon_2018_PLoS.One_13_e0205524 |
Author(s) : Rochon PA , Gruneir A , Bell CM , Savage R , Gill SS , Wu W , Giannakeas V , Stall NM , Seitz DP , Normand SL , Zhu L , Herrmann N , McCarthy L , Faulkner C , Gurwitz JH , Austin PC , Bronskill SE |
Ref : PLoS ONE , 13 :e0205524 , 2018 |
Abstract : |
PubMedSearch : Rochon_2018_PLoS.One_13_e0205524 |
PubMedID: 30346974 |
Title : Cholinesterase Inhibitor Discontinuation: The Buck Stops Here - |
Author(s) : Herrmann N |
Ref : American Journal of Geriatry & Psychiatry , 26 :148 , 2018 |
PubMedID: 29174877 |
Title : Systematic Review of Sex-Specific Reporting of Data: Cholinesterase Inhibitor Example - Mehta_2017_J.Am.Geriatr.Soc_65_2213 |
Author(s) : Mehta N , Rodrigues C , Lamba M , Wu W , Bronskill SE , Herrmann N , Gill SS , Chan AW , Mason R , Day S , Gurwitz JH , Rochon PA |
Ref : J Am Geriatr Soc , 65 :2213 , 2017 |
Abstract : |
PubMedSearch : Mehta_2017_J.Am.Geriatr.Soc_65_2213 |
PubMedID: 28832937 |
Title : Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation - Mohammad_2017_Expert.Opin.Drug.Saf_16_1009 |
Author(s) : Mohammad D , Chan P , Bradley J , Lanctot K , Herrmann N |
Ref : Expert Opin Drug Safety , 16 :1009 , 2017 |
Abstract : |
PubMedSearch : Mohammad_2017_Expert.Opin.Drug.Saf_16_1009 |
PubMedID: 28678552 |
Title : Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease - Ruthirakuhan_2016_Expert.Opin.Pharmacother_17_2417 |
Author(s) : Ruthirakuhan M , Herrmann N , Suridjan I , Abraham EH , Farber I , Lanctot KL |
Ref : Expert Opin Pharmacother , 17 :2417 , 2016 |
Abstract : |
PubMedSearch : Ruthirakuhan_2016_Expert.Opin.Pharmacother_17_2417 |
PubMedID: 27825018 |
Title : Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments - Liu_2016_Curr.Alzheimer.Res_13_1134 |
Author(s) : Liu CS , Ruthirakuhan M , Chau SA , Herrmann N , Carvalho AF , Lanctot KL |
Ref : Curr Alzheimer Res , 13 :1134 , 2016 |
Abstract : |
PubMedSearch : Liu_2016_Curr.Alzheimer.Res_13_1134 |
PubMedID: 27137221 |
Title : A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients With Moderate to Severe Alzheimer Disease - Herrmann_2016_J.Am.Med.Dir.Assoc_17_142 |
Author(s) : Herrmann N , O'Regan J , Ruthirakuhan M , Kiss A , Eryavec G , Williams E , Lanctot KL |
Ref : J Am Med Dir Assoc , 17 :142 , 2016 |
Abstract : |
PubMedSearch : Herrmann_2016_J.Am.Med.Dir.Assoc_17_142 |
PubMedID: 26482056 |
Title : Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: a meta-analysis of randomized controlled trials - O'Regan_2015_J.Clin.Psychiatry_76_e1424 |
Author(s) : O'Regan J , Lanctot KL , Mazereeuw G , Herrmann N |
Ref : J Clin Psychiatry , 76 :e1424 , 2015 |
Abstract : |
PubMedSearch : O'Regan_2015_J.Clin.Psychiatry_76_e1424 |
PubMedID: 26646039 |
Title : Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012 - Herrmann_2013_Alzheimers.Res.Ther_5_S5 |
Author(s) : Herrmann N , Lanctot KL , Hogan DB |
Ref : Alzheimers Res Ther , 5 :S5 , 2013 |
Abstract : |
PubMedSearch : Herrmann_2013_Alzheimers.Res.Ther_5_S5 |
PubMedID: 24565367 |
Title : Does pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease relieve caregiver burden? - Levy_2012_Drugs.Aging_29_167 |
Author(s) : Levy K , Lanctot KL , Farber SB , Li A , Herrmann N |
Ref : Drugs & Aging , 29 :167 , 2012 |
Abstract : |
PubMedSearch : Levy_2012_Drugs.Aging_29_167 |
PubMedID: 22350526 |
Title : Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review - Seitz_2012_Int.Psychogeriatr__1 |
Author(s) : Seitz DP , Gill SS , Herrmann N , Brisbin S , Rapoport MJ , Rines J , Wilson K , Le Clair K , Conn DK |
Ref : Int Psychogeriatr , :1 , 2012 |
Abstract : |
PubMedSearch : Seitz_2012_Int.Psychogeriatr__1 |
PubMedID: 23083438 |
Title : Transdermal rivastigmine: management of cutaneous adverse events and review of the literature - Greenspoon_2011_CNS.Drugs_25_575 |
Author(s) : Greenspoon J , Herrmann N , Adam DN |
Ref : CNS Drugs , 25 :575 , 2011 |
Abstract : |
PubMedSearch : Greenspoon_2011_CNS.Drugs_25_575 |
PubMedID: 21623641 |
Title : Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's type - Pinto_2011_Ageing.Res.Rev_10_404 |
Author(s) : Pinto T , Lanctot KL , Herrmann N |
Ref : Ageing Res Rev , 10 :404 , 2011 |
Abstract : |
PubMedSearch : Pinto_2011_Ageing.Res.Rev_10_404 |
PubMedID: 21292041 |
Title : Antidepressants for agitation and psychosis in dementia - Seitz_2011_Cochrane.Database.Syst.Rev__CD008191 |
Author(s) : Seitz DP , Adunuri N , Gill SS , Gruneir A , Herrmann N , Rochon P |
Ref : Cochrane Database Syst Rev , :CD008191 , 2011 |
Abstract : |
PubMedSearch : Seitz_2011_Cochrane.Database.Syst.Rev__CD008191 |
PubMedID: 21328305 |
Title : Discontinuing cholinesterase inhibitors: results of a survey of Canadian dementia experts - Herrmann_2011_Int.Psychogeriatr_23_539 |
Author(s) : Herrmann N , Black SE , Li A , Lanctot KL |
Ref : Int Psychogeriatr , 23 :539 , 2011 |
Abstract : |
PubMedSearch : Herrmann_2011_Int.Psychogeriatr_23_539 |
PubMedID: 20849673 |
Title : Memantine in dementia: a review of the current evidence - Herrmann_2011_Expert.Opin.Pharmacother_12_787 |
Author(s) : Herrmann N , Li A , Lanctot K |
Ref : Expert Opin Pharmacother , 12 :787 , 2011 |
Abstract : |
PubMedSearch : Herrmann_2011_Expert.Opin.Pharmacother_12_787 |
PubMedID: 21385152 |
Title : Published randomized controlled trials of drug therapy for dementia often lack complete data on harm - Lee_2008_J.Clin.Epidemiol_61_1152 |
Author(s) : Lee PE , Fischer HD , Rochon PA , Gill SS , Herrmann N , Bell CM , Sykora K , Anderson GM |
Ref : J Clin Epidemiol , 61 :1152 , 2008 |
Abstract : |
PubMedSearch : Lee_2008_J.Clin.Epidemiol_61_1152 |
PubMedID: 18619812 |
Title : Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease - Herrmann_2008_CMAJ_179_1279 |
Author(s) : Herrmann N , Gauthier S |
Ref : Cmaj , 179 :1279 , 2008 |
Abstract : |
PubMedSearch : Herrmann_2008_CMAJ_179_1279 |
PubMedID: 19047609 |
Title : Treatment of moderate to severe Alzheimer's disease: rationale and trial design - Herrmann_2007_Can.J.Neurol.Sci_34 Suppl 1_S103 |
Author(s) : Herrmann N |
Ref : Can Journal of Neurology Sci , 34 Suppl 1 :S103 , 2007 |
Abstract : |
PubMedSearch : Herrmann_2007_Can.J.Neurol.Sci_34 Suppl 1_S103 |
PubMedID: 17469692 |
Title : A population-based study of cholinesterase inhibitor use for dementia - Herrmann_2007_J.Am.Geriatr.Soc_55_1517 |
Author(s) : Herrmann N , Gill SS , Bell CM , Anderson GM , Bronskill SE , Shulman KI , Fischer HD , Sykora K , Shi HS , Rochon PA |
Ref : J Am Geriatr Soc , 55 :1517 , 2007 |
Abstract : |
PubMedSearch : Herrmann_2007_J.Am.Geriatr.Soc_55_1517 |
PubMedID: 17697100 |
Title : Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease - Herrmann_2007_Can.J.Psychiatry_52_630 |
Author(s) : Herrmann N , Lanctot KL |
Ref : Can J Psychiatry , 52 :630 , 2007 |
Abstract : |
PubMedSearch : Herrmann_2007_Can.J.Psychiatry_52_630 |
PubMedID: 18020111 |
Title : Mental health-related drug utilization among older adults: prevalence, trends, and costs - Mamdani_2005_Am.J.Geriatr.Psychiatry_13_892 |
Author(s) : Mamdani M , Rapoport M , Shulman KI , Herrmann N , Rochon PA |
Ref : American Journal of Geriatry & Psychiatry , 13 :892 , 2005 |
Abstract : |
PubMedSearch : Mamdani_2005_Am.J.Geriatr.Psychiatry_13_892 |
PubMedID: 16223968 |
Title : The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease - Thompson_2004_Expert.Opin.Drug.Saf_3_425 |
Author(s) : Thompson S , Lanctot KL , Herrmann N |
Ref : Expert Opin Drug Safety , 3 :425 , 2004 |
Abstract : |
PubMedSearch : Thompson_2004_Expert.Opin.Drug.Saf_3_425 |
PubMedID: 15335298 |
Title : Canadian Outcomes Study in Dementia: study methods and patient characteristics - Sambrook_2004_Can.J.Psychiatry_49_417 |
Author(s) : Sambrook R , Herrmann N , Hebert R , McCracken P , Robillard A , Luong D , Yu A |
Ref : Can J Psychiatry , 49 :417 , 2004 |
Abstract : |
PubMedSearch : Sambrook_2004_Can.J.Psychiatry_49_417 |
PubMedID: 15362245 |
Title : The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approach - Wu_2003_CNS.Drugs_17_1045 |
Author(s) : Wu G , Lanctot KL , Herrmann N , Moosa S , Oh PI |
Ref : CNS Drugs , 17 :1045 , 2003 |
Abstract : |
PubMedSearch : Wu_2003_CNS.Drugs_17_1045 |
PubMedID: 14594444 |
Title : Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis - Lanctot_2003_CMAJ_169_557 |
Author(s) : Lanctot KL , Herrmann N , Yau KK , Khan LR , Liu BA , LouLou MM , Einarson TR |
Ref : Cmaj , 169 :557 , 2003 |
Abstract : |
PubMedSearch : Lanctot_2003_CMAJ_169_557 |
PubMedID: 12975222 |
Title : Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease - Lanctot_2003_J.Psychiatry.Neurosci_28_13 |
Author(s) : Lanctot KL , Herrmann N , LouLou MM |
Ref : J Psychiatry Neurosci , 28 :13 , 2003 |
Abstract : |
PubMedSearch : Lanctot_2003_J.Psychiatry.Neurosci_28_13 |
PubMedID: 12587847 |
Title : Cognitive pharmacotherapy of Alzheimer's disease and other dementias - Herrmann_2002_Can.J.Psychiatry_47_715 |
Author(s) : Herrmann N |
Ref : Can J Psychiatry , 47 :715 , 2002 |
Abstract : |
PubMedSearch : Herrmann_2002_Can.J.Psychiatry_47_715 |
PubMedID: 12420649 |
Title : Donepezil for behavioural disorders associated with Lewy bodies: a case series - Lanctot_2000_Int.J.Geriatr.Psychiatry_15_338 |
Author(s) : Lanctot KL , Herrmann N |
Ref : Int J Geriatr Psychiatry , 15 :338 , 2000 |
Abstract : |
PubMedSearch : Lanctot_2000_Int.J.Geriatr.Psychiatry_15_338 |
PubMedID: 10767734 |
Title : Recent advances in geriatric psychopharmacology - Naranjo_1995_Drugs.Aging_7_184 |
Author(s) : Naranjo CA , Herrmann N , Mittmann N , Bremner KE |
Ref : Drugs & Aging , 7 :184 , 1995 |
Abstract : |
PubMedSearch : Naranjo_1995_Drugs.Aging_7_184 |
PubMedID: 8535049 |